Managed Healthcare Executive Newsletter

To view this email as a web page, click here.

Access to broad snapshot of the patient’s pharmacy and medical data can help spot and address drug misuse.

The Biggest Obstacle to Cancer Biosimilar Development

Biosimilar drugs are poised to transform the cancer drug market—so why is uptake so slow?

3 Creative Ways Biologic Innovators are Protecting Their Turf

As more biosimilar agents are approved by the FDA, biologic manufacturers are looking for unique ways to hold on to market share.

DIGITAL EDITION

Check out our February issue featuring:

• 6 Healthcare Technologies Coming in the Next Decade
• The Biggest Barriers to Home Healthcare
• The Impact of Big Data on Medical Decisions

4 healthcare predictions for 2019

Read what three healthcare leaders have to say about the changes they anticipate in the healthcare industry this year, including machine learning, operational efficiency, and the patient as consumer. Learn More.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT